Rapid US FDA Review For Roche’s SMA Contender

Physicians Keen On Oral Formulation

 
• By Andrew McConaghie

Roche files quickly to keep up with Novartis’s gene therapy Zolgensma.

Roche_HQ
Roche wants to reach the market early to compete with rivals Novartis

More from Business

More from Scrip